# PepVero

> PepVero is an educational, research-only platform providing evidence-based research, safety profiles, and regulatory tracking for therapeutic peptides. Every claim is sourced to a DOI or PubMed ID. Content is for informational and research purposes only and is not medical advice.

## Editorial policy

- Evidence-first: no claim is published without a peer-reviewed source.
- Safety warnings and limitations are always included.
- Risk levels and evidence scores are computed and editorially reviewed.
- Available in English, Hebrew, Spanish, Russian, Hindi, Chinese, and Arabic (prefix routes with /he, /es, /ru, /hi, /zh or /ar).

## Core tools

- [Peptide Directory](https://pepvero.com/peptides): Searchable index of peptides with evidence scores and risk profiles.
- [Research Studies](https://pepvero.com/research/studies): Peer-reviewed studies, manually verified against DOI/PubMed.
- [Regulatory Map](https://pepvero.com/regulatory): Legal status of peptides across jurisdictions.
- [Clinical Trials](https://pepvero.com/clinical-trials): Ongoing peptide clinical trials.
- [Compare Peptides](https://pepvero.com/compare): Side-by-side comparison of up to 3 peptides.
- [Methodology](https://pepvero.com/methodology): How evidence scores are calculated.

## Educational guides

- [What Are Peptides?](https://pepvero.com/learn/what-are-peptides)
- [How to Choose a Peptide Provider](https://pepvero.com/learn/how-to-choose-peptide-provider)
- [Research Use Only](https://pepvero.com/learn/research-use-only)
- [Glossary](https://pepvero.com/glossary)

## Research spotlights
- [The GLP-1 Compounding Crackdown](https://pepvero.com/spotlight/compounding-crackdown): Why grey-market peptides got riskier as the FDA moves toward a permanent ban.
- [Orforglipron: The First Oral GLP-1 Pill](https://pepvero.com/spotlight/orforglipron): The first FDA-approved GLP-1 taken as a daily pill.
- [Retatrutide: The Triple-Agonist](https://pepvero.com/spotlight/retatrutide): ~28% average weight loss in TRIUMPH-1, the highest yet in a phase 3 obesity trial.
- [BPC-157 & Longevity Peptides](https://pepvero.com/spotlight/bpc-157-longevity): What the 2026 research really shows — and the human-data gap.
- [Tirzepatide (Mounjaro) in Israel](https://pepvero.com/spotlight/tirzepatide-israel): The GLP-1/GIP dual agonist — SURMOUNT data, Israel status, and safety.
- [Semaglutide vs Tirzepatide](https://pepvero.com/spotlight/semaglutide-vs-tirzepatide): Ozempic, Wegovy, semaglutide and Mounjaro explained — mechanism and efficacy.
- [NAD+ & Longevity](https://pepvero.com/spotlight/nad-longevity): What the research shows on NMN, NR and aging — and where hype skips the data.
- [Tesamorelin: The GHRH Analog](https://pepvero.com/spotlight/tesamorelin): What the research really shows on this FDA-approved GHRH peptide.

## CRISPR & gene-editing knowledge hub
A sourced, evidence-graded explainer series on CRISPR gene editing for an educated general audience — covering how it works, its clinical and agricultural applications, and open scientific and ethical questions. Available in English, Hebrew, Spanish, Russian, Hindi, Chinese, and Arabic.
- [Is CRISPR Safe? Understanding the Risks, Off-Target Effects, and Clinical Trial Safety Profile](https://pepvero.com/crispr/is-crispr-safe): CRISPR-Cas9 gene editing holds immense therapeutic promise, but its safety is a primary focus of ongoing research and clinical development. Key concerns include off-target effects,
- [CRISPR in Cancer Treatment: Engineering T-Cells for Advanced Therapies](https://pepvero.com/crispr/crispr-cancer-treatment): CRISPR-Cas9 technology is revolutionizing cancer research by enabling precise genetic modifications in immune cells, particularly T-cells, to enhance their ability to target and de
- [The Cost of CRISPR Gene Therapy: Understanding Pricing, Access, and the Future of Approved Treatments](https://pepvero.com/crispr/crispr-gene-therapy-cost): Approved CRISPR-based gene therapies, such as Casgevy for sickle cell disease, carry high list prices exceeding $2 million, reflecting significant research and development costs, c
- [CRISPR: A People-First Guide to Gene-Editing Research](https://pepvero.com/crispr): CRISPR is a family of gene-editing technologies adapted from a bacterial immune system. It lets researchers make targeted changes to DNA using a guide RNA and a Cas enzyme such as 
- [What Is CRISPR?](https://pepvero.com/crispr/what-is-crispr): CRISPR stands for "clustered regularly interspaced short palindromic repeats." It is a technology that scientists use to make targeted changes to the DNA of living organisms. It wa
- [How Does CRISPR Work?](https://pepvero.com/crispr/how-does-crispr-work): CRISPR-Cas9 works in three stages. First, a short guide RNA directs the Cas9 enzyme to a matching DNA sequence. Second, after recognizing a nearby signal called a PAM, Cas9 cuts bo
- [CRISPR vs. Other Gene-Editing Tools](https://pepvero.com/crispr/crispr-vs-other-gene-editing-tools): CRISPR is not the only way to edit genes, but it is the most accessible. Earlier tools — zinc-finger nucleases (ZFNs) and TALENs — could edit DNA but required engineering a new cus
- [CRISPR in Medicine: Approved Therapies, Trials & Research](https://pepvero.com/crispr/crispr-medical-applications): CRISPR is already an approved medical therapy for two blood disorders, but most of its medical uses are still experimental. In December 2023 the FDA approved Casgevy (exa-cel) for 
- [CRISPR in Agriculture & Food: Crops, GMOs & Regulation](https://pepvero.com/crispr/crispr-agriculture-food): CRISPR is used in agriculture to make small, targeted changes to a plant or animal's own DNA — improving traits like nutrition, shelf life, or disease resistance without adding gen
- [CRISPR Delivery & Safety: Getting the Edit Where It Needs to Go](https://pepvero.com/crispr/crispr-delivery-and-safety): The biggest challenges in CRISPR are delivery (getting the editing machinery into the right cells) and safety (making sure it edits only the intended DNA). Today's approved therapi
- [CRISPR Ethics & the Germline: Where Society Draws the Line](https://pepvero.com/crispr/crispr-ethics-germline): The central ethical divide in CRISPR is between somatic editing (changing the cells of one consenting patient, which is accepted and approved for some diseases) and germline editin

## Featured peptides
- [Semaglutide](https://pepvero.com/peptides/semaglutide): GLP-1 receptor agonist for obesity and T2D
- [Liraglutide](https://pepvero.com/peptides/liraglutide): GLP-1 agonist for obesity and T2D
- [Tirzepatide](https://pepvero.com/peptides/tirzepatide): GIP/GLP-1 dual receptor agonist
- [Semaglutide oral](https://pepvero.com/peptides/semaglutide-oral): Oral once-daily GLP-1 agonist formulation
- [Retatrutide](https://pepvero.com/peptides/retatrutide): Triple GIP/GLP-1/glucagon receptor agonist
- [Tesofensine](https://pepvero.com/peptides/tesofensine): Triple monoamine reuptake inhibitor investigated for obesity and metabolic disorders.
- [Ghrelin](https://pepvero.com/peptides/ghrelin): Hunger hormone and GH secretagogue
- [Exenatide](https://pepvero.com/peptides/exenatide): GLP-1 agonist (Byetta/Bydureon)
- [Survodutide](https://pepvero.com/peptides/survodutide): Glucagon/GLP-1 dual agonist for obesity (SYNCHRONIZE-1)
- [Glucagon](https://pepvero.com/peptides/glucagon): Counter-regulatory hormone for glucose control
- [Tesamorelin](https://pepvero.com/peptides/tesamorelin): GHRH analog for HIV lipodystrophy
- [Larazotide (AT-1001)](https://pepvero.com/peptides/larazotide): A synthetic octapeptide designed to modulate intestinal tight junctions for therapeutic purposes.
- [Lutathera (Lu-177 DOTATATE)](https://pepvero.com/peptides/lutathera): Radioactive peptide for neuroendocrine cancer
- [Melphalan Flufenamide](https://pepvero.com/peptides/melphalan-flufenamide): PDC peptide-conjugate for multiple myeloma
- [Glucagon-like Peptide-2 (GLP-2)](https://pepvero.com/peptides/glp-2): Intestinal growth factor for short bowel syndrome
- [ACTH](https://pepvero.com/peptides/acth): Adrenocorticotropic hormone
- [GLP-1 Combination (Semaglutide + Cagrilintide)](https://pepvero.com/peptides/glp1-amylin-combo): Dual amylin/GLP-1 agonist for superior weight loss
- [CJC-1295](https://pepvero.com/peptides/cjc-1295): Long-acting GHRH analog
- [GHK-Cu](https://pepvero.com/peptides/ghk-cu): Copper peptide for skin regeneration
- [Sermorelin](https://pepvero.com/peptides/sermorelin): GHRH analog for GH deficiency
- [Oral Peptide Delivery (SNAC)](https://pepvero.com/peptides/oral-snac-delivery): Sodium caprylic acid absorption enhancer
- [Thymosin Beta-4 / TB-500](https://pepvero.com/peptides/thymosin-beta-4): Regenerative peptide for wound healing
- [Cagrilintide](https://pepvero.com/peptides/cagrilintide): Amylin analog for obesity
- [Substance P](https://pepvero.com/peptides/substance-p): Neurotransmitter for pain signaling
- [Peptide-Drug Conjugate (PDC)](https://pepvero.com/peptides/pdc-oncology): Tumor-targeted peptide payload platform
- [BPC-157](https://pepvero.com/peptides/bpc-157): Synthetic 15-amino acid peptide derived from gastric juice protein
- [Neuropeptide Y (NPY)](https://pepvero.com/peptides/neuropeptide-y): Stress and anxiety regulator
- [PT-141 / Bremelanotide](https://pepvero.com/peptides/pt-141): Melanocortin agonist for sexual dysfunction
- [Stellate Ganglion Block (SGB)](https://pepvero.com/peptides/sgb): Regional anesthesia for complex pain syndromes
- [Apelin](https://pepvero.com/peptides/apelin): Vasoactive peptide for cardiovascular health
- [LY3819253](https://pepvero.com/peptides/ly3819253): Next-gen GLP-1/GCG dual agonist
- [Combinatorial Peptide Protocols](https://pepvero.com/peptides/combo-peptides): Synergistic multi-peptide treatment regimens
- [LL-37](https://pepvero.com/peptides/ll-37): Antimicrobial host defense peptide
- [Peptide YY (PYY)](https://pepvero.com/peptides/peptide-yy): Satiety hormone for appetite regulation
- [Oxytocin](https://pepvero.com/peptides/oxytocin): Neurohormone for social behavior and stress
- [Cholecystokinin (CCK)](https://pepvero.com/peptides/cck): Satiety and pancreatic enzyme regulator
- [MK-677](https://pepvero.com/peptides/mk-677): Oral growth hormone secretagogue
- [Intranasal Peptide Delivery](https://pepvero.com/peptides/intranasal-delivery): Non-invasive nasal absorption systems
- [Gonadorelin](https://pepvero.com/peptides/gonadorelin): GnRH agonist for reproductive health
- [Angiotensin-(1-7)](https://pepvero.com/peptides/angiotensin-1-7): Vasodilator for hypertension and cardiac protection

## Sitemap
- [XML Sitemap](https://pepvero.com/functions/sitemap)